Latest filing published 15 Feb 2024 for Telomir Pharmaceuticals, Inc., €260k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -56.5%Entry US$9.02 · Close at T+365 US$3.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Bay Shore Trust: trading record in brief
Bay Shore Trust is a declared insider of Telomir Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Altogether 3 filings, all relating to 13 February 2024.
Purchases make up the whole of the open-market record (3 purchases, €897k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €318k.
The newest entry dates from 15 February 2024: an open-market purchase of €318k, in Telomir Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bay Shore Trust
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,000 shares@ US$7.0044.9% of flowCommon StockSEC:0000897069-24-000395:1Canonical exit: 13 May 2024 (T+90)
- 49,000 shares@ US$7.00100.0% of flowCommon StockSEC:0000897069-24-000395:0Canonical exit: 13 May 2024 (T+90)
2 of 2 declarations